Pulse Biosciences (PLSE) Receivables - Other (2020 - 2021)

Pulse Biosciences (PLSE) recorded quarterly Receivables - Other of $8.4 million in Q2 2021, up 584.46% quarter-over-quarter from $1.2 million in Q4 2020.

Pulse Biosciences (PLSE) Receivables - Other (2020 - 2021) Analysis & Trends

Pulse Biosciences' Receivables - Other history runs 2 years deep, the most recent figure standing at $8.4 million for Q2 2021.

  • In Q2 2021, Receivables - Other changed N/A year-over-year to $8.4 million; the TTM figure through Jun 2021 stood at $8.4 million (changed N/A YoY), while the FY2020 annual figure was $1.2 million, changed N/A from the prior year.
  • Receivables - Other was $8.4 million for Q2 2021 at Pulse Biosciences, up from $1.2 million in the prior quarter.
  • In the past five years, Receivables - Other ranged from a high of $8.4 million in Q2 2021 to a low of $1.2 million in Q4 2020.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Intuitive Surgical 148.09 Bn 143.69 Bn 1.83 Bn
2 Becton Dickinson 41.00 Bn 39.99 Bn 2.15 Bn
3 Medline 30.38 Bn 36.22 Bn 1.84 Bn
4 Resmed 28.22 Bn 26.56 Bn 890.98 Mn
5 West Pharmaceutical Services 23.72 Bn 23.19 Bn 296.40 Mn
6 Solventum 13.33 Bn 13.33 Bn 1.10 Bn
7 Cooper Companies 13.12 Bn 12.99 Bn 735.40 Mn
8 Align Technology 12.86 Bn 11.80 Bn 736.59 Mn
9 Baxter International 10.51 Bn 8.47 Bn 891.00 Mn
10 Pulse Biosciences 1.68 Bn 1.68 Bn -

Historic Data

Download Data
DateValue
Jun 30, 2021 8.37 Mn
Jun 30, 2021 8.37 Mn
Dec 31, 2020 1.22 Mn
Dec 31, 2020 1.22 Mn